Company Filing History:
2 out of 28 
1 out of 363 
Years Active: 2003-2008
Title: Innovations of Jules Remenar in Pharmaceutical Sciences
Introduction
Jules Remenar, an accomplished inventor based in Framingham, MA, has made significant contributions to the field of pharmaceutical sciences with his innovative inventions. With a remarkable portfolio that includes three patents, his work emphasizes the development of novel pharmaceutical compositions aimed at treating various health conditions.
Latest Patents
Among his latest innovations, Remenar has developed patents that focus on topiramate salts and their clinical applications. His work encompasses the creation of novel salts of topiramate, including topiramate sodium, lithium, and potassium, along with different polymorphs and other forms. These compositions serve diverse therapeutic purposes, addressing ailments such as seizures, obesity, migraines, and more.
Another significant patent by Remenar involves CIS-itraconazole crystalline forms. This invention offers unique soluble conazole crystalline forms, including itraconazole and posaconazole, which are pivotal in treating systemic and local fungal infections. His research in this area not only showcases his inventive prowess but also provides practical solutions for pharmaceutical applications.
Career Highlights
Throughout his career, Jules Remenar has collaborated with reputable companies like Transform Pharmaceuticals, Inc. and Ortho-McNeil Pharmaceutical Corporation. His work in these esteemed organizations has propelled advancements in the development of effective pharmaceutical solutions.
Collaborations
In his journey of innovation, Remenar has worked alongside talented individuals such as Matthew Lynn Peterson and Örn Almarsson. Their collaborative efforts have been instrumental in pushing the boundaries of research and enriching the pharmaceutical domain.
Conclusion
Jules Remenar stands out as a leading inventor whose contributions to pharmaceutical innovations have provided valuable solutions for treating various health conditions. His dedication to research and collaboration with industry experts continues to pave the way for future innovations in the pharmaceutical landscape.